Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$29.6 - $36.56 $581,669 - $718,440
19,651 Added 328.89%
25,626 $787,000
Q1 2023

May 12, 2023

BUY
$32.77 - $39.4 $169,420 - $203,698
5,170 Added 642.24%
5,975 $215,000
Q4 2022

Feb 13, 2023

SELL
$39.17 - $44.04 $7,207 - $8,103
-184 Reduced 18.6%
805 $31,000
Q3 2022

Nov 07, 2022

BUY
$39.88 - $44.65 $39,441 - $44,158
989 New
989 $39,000
Q1 2022

May 16, 2022

SELL
$37.46 - $42.44 $359,653 - $407,466
-9,601 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$35.17 - $42.48 $337,667 - $407,850
9,601 New
9,601 $382,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.